Fund Overview of ICICI Prudential Nifty Pharma Index Fund - Idcw
-
₹94.9 CrAUM
-
₹16.62NAV
-
0.98%Expense Ratio
-
EquityFund Category
Returns of ICICI Prudential Nifty Pharma Index Fund - Idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 1.19% | NA | 6.12% |
| 6 Months | 9.14% | NA | 12.92% |
| 1 Year | -5.34% | -5.34% | 6.04% |
| 2 Years | 41.01% | 18.75% | 24.93% |
Asset Allocation
equities
99.80%other assets or cash equivalents
0.20%ICICI Prudential Nifty Pharma Index Fund - Idcw is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 14 Dec 2022, the fund aims Long term wealth creation solution. An index fund that seeks to track returns by investing in a basket of Nifty Pharma Index stocks and aims to achieve returns of the stated index, subject to tracking error. It manages assets worth ₹94.9 crore as on Thu Jul 31, 2025. The expense ratio stands at 0.98%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout ICICI Prudential Nifty Pharma Index Fund - Idcw
The portfolio allocation consists of 99.80% in equities, 0.20% in other assets or cash equivalents. Managed by Nishit Patel, it has delivered a return of -5.34% in the last year, a total return since inception of 21.01%.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
Tata India Pharma & Healthcare Fund Regular-growth  |
₹1,339 | -1.01% | -0.31% | -2.45% | 21.59% | 16.66% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from ICICI Prudential Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
|
₹6,104 | -0.93% | -0.65% | 12.92% | 1.91% | 26.54% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth
|
₹6,104 | -0.86% | -0.44% | 13.38% | 2.75% | 27.60% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw
|
₹6,104 | -0.93% | -0.65% | 12.92% | 1.91% | 26.54% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
|
₹6,104 | -0.86% | -0.44% | 13.38% | 2.75% | 27.60% |
|
ICICI Prudential Nifty Healthcare Etf - Growth
|
₹146 | 0.09% | -0.81% | 9.25% | -1.30% | 20.85% |
|
ICICI Prudential Nifty Pharma Index Fund - Growth
|
₹95 | -0.79% | -2.09% | 6.44% | -7.13% | - |
|
ICICI Prudential Nifty Pharma Index Fund Direct - Growth
|
₹95 | -0.74% | -1.94% | 6.77% | -6.58% | - |
|
ICICI Prudential Nifty Pharma Index Fund Direct - Idcw
|
₹95 | -0.74% | -1.94% | 6.77% | -6.58% | - |
growth is based on 1-month returns of the fundsMutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Tax Information
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular-growth |
₹1,339 | ₹30.46 | 21.59% | 16.66% | - |
| Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth |
₹166 | ₹20.67 | 19.25% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 22.49% | ₹21.33 Cr |
| Cipla Ltd | Healthcare | 10.69% | ₹10.14 Cr |
| Divi's Laboratories Ltd | Healthcare | 10.24% | ₹9.71 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.45% | ₹8.97 Cr |
| Lupin Ltd | Healthcare | 5.70% | ₹5.41 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.78% | ₹4.54 Cr |
| Laurus Labs Ltd | Healthcare | 4.18% | ₹3.97 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.93% | ₹3.73 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.90% | ₹3.70 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.54% | ₹3.36 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.31% | ₹3.14 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.96% | ₹2.81 Cr |
| Biocon Ltd | Healthcare | 2.87% | ₹2.73 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.50% | ₹2.37 Cr |
| Abbott India Ltd | Healthcare | 2.19% | ₹2.08 Cr |
| Gland Pharma Ltd | Healthcare | 2.01% | ₹1.90 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.75% | ₹1.66 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.41% | ₹1.34 Cr |
| Natco Pharma Ltd | Healthcare | 1.04% | ₹0.99 Cr |
| Granules India Ltd | Healthcare | 0.84% | ₹0.80 Cr |
| Repo | Unspecified | 0.16% | ₹0.15 Cr |
| Net Current Assets | Unspecified | 0.04% | ₹0.04 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular-growth |
₹30.46 | 21.59% | 16.66% | 32.01 |
growth is based on 5Y returns of the funds
ICICI Prudential Nifty Pharma Index Fund - Idcw
What is the current AUM of ICICI Prudential Nifty Pharma Index Fund - Idcw?
As of Thu Jul 31, 2025, ICICI Prudential Nifty Pharma Index Fund - Idcw manages assets worth ₹94.9 crore
How has ICICI Prudential Nifty Pharma Index Fund - Idcw performed recently?
- 3 Months: 1.19%
- 6 Months: 9.14%
What is the long-term performance of ICICI Prudential Nifty Pharma Index Fund - Idcw?
- Since Inception: 21.01%
What is the portfolio composition of ICICI Prudential Nifty Pharma Index Fund - Idcw?
Equity: 99.80%, Others: 0.20%.
Who manages ICICI Prudential Nifty Pharma Index Fund - Idcw?
ICICI Prudential Nifty Pharma Index Fund - Idcw is managed by Nishit Patel from ICICI Prudential Mutual Fund.
What is the market-cap allocation of ICICI Prudential Nifty Pharma Index Fund - Idcw?
Large Cap: 70.00%, Mid Cap: 24.35%, Small Cap: 5.66%.
Which are the top companies ICICI Prudential Nifty Pharma Index Fund - Idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 22.49% of the fund's portfolio
- Cipla Ltd – 10.69% of the fund's portfolio
- Divi's Laboratories Ltd – 10.24% of the fund's portfolio
- Dr. Reddy's Laboratories Ltd – 9.45% of the fund's portfolio
- Lupin Ltd – 5.70% of the fund's portfolio
Which are the major sectors ICICI Prudential Nifty Pharma Index Fund - Idcw focuses on?
- Healthcare – 99.80% of the fund's portfolio
- Unspecified – 0.20% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
